PTC Therapeutics Inc. has granted non-statutory stock options for a total of 2,000 shares and 1,990 restricted stock units (RSUs) to two new employees. The stock options have an exercise price of $66.80 per share and a 10-year term. Vesting for the stock options will occur over four years, with 25% vesting after the first year and the remainder vesting in equal quarterly installments. The RSUs will also vest over four years, with 25% vesting on each annual anniversary of the new hire date.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PTC Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY07036) on October 27, 2025, and is solely responsible for the information contained therein.